Since AR-negative TNBC is more commonly diagnosed among African-American women and is believed to underlie the stark racial disparity in breast cancer outcomes in the US [105], we examined the race-wise expression of the centrosome clustering genes KIFC1 (Figure 5A), AURKB (Figure 5B), BIRC5 (Figure 5C), and CDCA8 (Figure 5D), as well as the race-wise expression profiles of ATAD2 (Figure 5E), E2F1 (Figure 5F), and FOXM1 (Figure 5G). The gene discussed is ATAD2; the disease is breast carcinoma.